Roadmap for the treatment of heart failure patients after hospital discharge: an interdisciplinary consensus paper.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
27 Jan 2020
Historique:
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 20 2 2021
Statut: epublish

Résumé

The transition period from the hospital to the outpatient setting is a critical phase when managing heart failure. A well-structured transition is paramount and helps to ensure a tight follow-up schedule for the heart failure patient, thereby improving treatment outcomes. This article aims to provide guidance for the first three follow-up visits after hospital discharge, with a focus on monitoring heart failure patients and up-titrating their medication in primary care.

Identifiants

pubmed: 32027753
doi: 10.4414/smw.2020.20159
pii: Swiss Med Wkly. 2020;150:w20159
doi:
pii:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20159

Auteurs

Christian Mueller (C)

Universitäres Herzzentrum und Cardiovascular Research Institute Basel (CRIB), Universitätsspital Basel, Switzerland.

Klaus Bally (K)

Universitäres Zentrum für Hausarztmedizin beider Basel, Universität Basel, Switzerland.

Marc Buser (M)

Kantonsspital St. Gallen, Switzerland.

Andreas J Flammer (AJ)

Universitäres Herzzentrum, UniversitätsSpital Zürich, Switzerland.

Jean-Michel Gaspoz (JM)

Clinique des Grangettes, Chêne-Bougeries, Switzerland.

François Mach (F)

Hôpitaux Universitaires de Genève, Switzerland.

Giorgio Moschovitis (G)

Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano, Switzerland.

Matthias Paul (M)

Kantonsspital Luzern, Switzerland.

Andreas Zeller (A)

Universitäres Zentrum für Hausarztmedizin beider Basel, Universität Basel, Switzerland.

Ellen Heitlinger (E)

H+O Communications Ltd., Küssnacht am Rigi, Switzerland.

Bianca Fay (B)

Novartis Pharma Schweiz AG, Rotkreuz, Switzerland.

Thomas Rosemann (T)

Institut für Hausarztmedizin, Universität Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH